Skip to main content

Fasting

13
Pipeline Programs
3
Companies
15
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
12
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

JW Pharmaceutical
JW PharmaceuticalKorea - Seoul
1 program
1
Early recoveryPhase 21 trial
Active Trials
NCT01642953Unknown109Est. Aug 2014
Dr. Reddy's Laboratories
12 programs
12
Amlodipine Besylate/Benazepril HClPhase 11 trial
CIPRO®XRPhase 11 trial
ClopidogrelPhase 11 trial
ClopidogrelPhase 11 trial
DesloratadinePhase 11 trial
+7 more programs
Active Trials
NCT01506011Completed50Est. Apr 2007
NCT01372345Completed43Est. Mar 2005
NCT01506713Completed53Est. Sep 2006
+9 more trials
Human BioSciences
Human BioSciencesWV - Martinsburg
2 programs
Satiety Effects on the Neural Valuation of FoodN/A1 trial
Time Restrictive FeedingN/A1 trial
Active Trials
NCT01721187Completed60Est. Jul 2014
NCT03569852Completed21Est. Mar 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
JW PharmaceuticalEarly recovery
Dr. Reddy's LaboratoriesOlanzapine
Dr. Reddy's LaboratoriesClopidogrel
Dr. Reddy's LaboratoriesLevocetirizine DiHCl
Dr. Reddy's LaboratoriesMycophenolate Mofetil
Dr. Reddy's LaboratoriesAmlodipine Besylate/Benazepril HCl
Dr. Reddy's LaboratoriesOlanzapine OD Tablets 5 mg
Dr. Reddy's LaboratoriesClopidogrel
Dr. Reddy's LaboratoriesDesloratadine
Dr. Reddy's LaboratoriesCIPRO®XR
Dr. Reddy's LaboratoriesPantoprazole Sodium
Dr. Reddy's LaboratoriesReminyl
Dr. Reddy's LaboratoriesTerbinafine Hydrochloride Tablets, 250 mg
Human BioSciencesTime Restrictive Feeding
Human BioSciencesSatiety Effects on the Neural Valuation of Food

Clinical Trials (15)

Total enrollment: 685 patients across 15 trials

NCT01642953JW PharmaceuticalEarly recovery

Early Recovery After Gastric Cancer Surgery

Start: Jul 2012Est. completion: Aug 2014109 patients
Phase 2Unknown
NCT01503398Dr. Reddy's LaboratoriesOlanzapine

Bioequivalence Study of Olanzapine Tablets, 5 mg of Dr. Reddy's Under Fasting Conditions

Start: Aug 2011Est. completion: Sep 201148 patients
Phase 1Completed
NCT01621750Dr. Reddy's LaboratoriesClopidogrel

Bioequivalence Study of Clopidogrel Tablets 300 mg Under Fasting Conditions

Start: Aug 2008Est. completion: Sep 200868 patients
Phase 1Completed
NCT01506076Dr. Reddy's LaboratoriesLevocetirizine DiHCl

Bioequivalence Study of Levocetirizine DiHCl Tablets 5mg of Dr. Reddy's Under Fasting Conditions

Start: Dec 2007Est. completion: Jan 200829 patients
Phase 1Completed
NCT01283841Dr. Reddy's LaboratoriesMycophenolate Mofetil

Bioequivalence Study of Mycophenolate Mofetil 500 mg Tablets of Dr.Reddy's Laboratories Limited Under Fasting Conditions

Start: Nov 2007Est. completion: Dec 200748 patients
Phase 1Completed
NCT01506011Dr. Reddy's LaboratoriesAmlodipine Besylate/Benazepril HCl

Bioequivalence Study of Amlodipine Besylate/Benazepril HCl 10 mg/40 mg Capsules of Dr. Reddy's Under Fasting Conditions

Start: Mar 2007Est. completion: Apr 200750 patients
Phase 1Completed
NCT01503437Dr. Reddy's LaboratoriesOlanzapine OD Tablets 5 mg

Bioequivalence Study of Olanzapine Orally Disintegrating Tablets, 5 mg Under Fasting Condition

Start: Nov 2006Est. completion: Dec 200622 patients
Phase 1Completed
NCT01506713Dr. Reddy's LaboratoriesClopidogrel

Bioequivalence Study of Clopidogrel Tablets 75 mg of Dr. Reddy's Under Fasting Conditions

Start: Sep 2006Est. completion: Sep 200653 patients
Phase 1Completed
NCT01314339Dr. Reddy's LaboratoriesDesloratadine

Bioavailability Study of Dr. Reddy's Desloratadine Tablets, 5 mg Under Fasting Conditions.

Start: Dec 2005Est. completion: Feb 200628 patients
Phase 1Completed
NCT01372345Dr. Reddy's LaboratoriesCIPRO®XR

Bioavailability Study of Ciprofloxacin 1000 mg ER Tablets of Dr. Reddy's Under Fasting Conditions

Start: Feb 2005Est. completion: Mar 200543 patients
Phase 1Completed
NCT01283919Dr. Reddy's LaboratoriesPantoprazole Sodium

Bioequivalence Study of Pantoprazole Sodium DR Tablets 40 mg of Dr. Reddy's Laboratories Limited Under Fasting Condition

Start: Oct 2004Est. completion: Dec 200442 patients
Phase 1Completed
NCT01372280Dr. Reddy's LaboratoriesReminyl

Galantamine Bioequivalence Study of Dr. Reddy's Under Fasting Condition

Start: Oct 2004Est. completion: Nov 200428 patients
Phase 1Completed
NCT01286688Dr. Reddy's LaboratoriesTerbinafine Hydrochloride Tablets, 250 mg

Bioequivalence Study of Terbinafine Hydrochloride Tablets, 250 mg of Dr. Reddy's Under Fasting Conditions

Start: Jan 2002Est. completion: Mar 200236 patients
Phase 1Completed
NCT03569852Human BioSciencesTime Restrictive Feeding

Time Restricted Feeding in Male Runners

Start: Jul 2018Est. completion: Mar 202021 patients
N/ACompleted
NCT01721187Human BioSciencesSatiety Effects on the Neural Valuation of Food

Satiety Effects on the Neural Valuation of Food

Start: Oct 2012Est. completion: Jul 201460 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.